BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17555470)

  • 1. Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas.
    Ponzoni M; Berger F; Chassagne-Clement C; Tinguely M; Jouvet A; Ferreri AJ; Dell'Oro S; Terreni MR; Doglioni C; Weis J; Cerati M; Milani M; Iuzzolino P; Motta T; Carbone A; Pedrinis E; Sanchez J; Blay JY; Reni M; Conconi A; Bertoni F; Zucca E; Cavalli F; Borisch B;
    Br J Haematol; 2007 Aug; 138(3):316-23. PubMed ID: 17555470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas.
    D'Haene N; Catteau X; Maris C; Martin B; Salmon I; Decaestecker C
    Br J Haematol; 2008 Feb; 140(4):402-10. PubMed ID: 18081894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas.
    Ferreri AJ; Dell'Oro S; Capello D; Ponzoni M; Iuzzolino P; Rossi D; Pasini F; Ambrosetti A; Orvieto E; Ferrarese F; Arrigoni G; Foppoli M; Reni M; Gaidano G
    Br J Haematol; 2004 Sep; 126(5):657-64. PubMed ID: 15327516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system lymphoma: immunohistochemical profile and prognostic significance.
    Raoux D; Duband S; Forest F; Trombert B; Chambonnière ML; Dumollard JM; Khaddage A; Gentil-Perret A; Péoc'h M
    Neuropathology; 2010 Jun; 30(3):232-40. PubMed ID: 19925562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-grade primary central nervous system lymphoma in immunocompetent patients.
    Jahnke K; Thiel E; Schilling A; Herrlinger U; Weller M; Coupland SE; Krümpelmann U; Stein H; Korfel A
    Br J Haematol; 2005 Mar; 128(5):616-24. PubMed ID: 15725082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement.
    Lee KW; Yi J; Choi IS; Kim JH; Bang SM; Kim DW; Im SA; Kim TY; Yoon SS; Lee JS; Bang YJ; Park S; Kim BK; Cho HI; Heo DS
    Ann Hematol; 2009 Sep; 88(9):829-38. PubMed ID: 19172274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma.
    Hasselblom S; Sigurdadottir M; Hansson U; Nilsson-Ehle H; Ridell B; Andersson PO
    Br J Haematol; 2007 May; 137(4):364-73. PubMed ID: 17456059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma.
    He M; Zuo C; Wang J; Liu J; Jiao B; Zheng J; Cai Z
    Neuro Oncol; 2013 Jun; 15(6):727-34. PubMed ID: 23482670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
    Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
    Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary central nervous system lymphomas: a 30-year experience at a single institution.
    Nuckols JD; Liu K; Burchette JL; McLendon RE; Traweek ST
    Mod Pathol; 1999 Dec; 12(12):1167-73. PubMed ID: 10619271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-6 predicts improved prognosis in primary central nervous system lymphoma.
    Levy O; Deangelis LM; Filippa DA; Panageas KS; Abrey LE
    Cancer; 2008 Jan; 112(1):151-6. PubMed ID: 17999414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary T-cell lymphoma of the central nervous system.
    Ferracini R; Bergmann M; Pileri S; Rigobello L; Azzolini U; Manetto V; Poggi S; Sabattini E; Frank G; Spagnolli F
    Clin Neuropathol; 1995; 14(3):125-9. PubMed ID: 7671452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system lymphomas. Immunohistochemical and clinicopathologic study of 26 autopsy cases.
    Nakhleh RE; Manivel JC; Hurd D; Sung JH
    Arch Pathol Lab Med; 1989 Sep; 113(9):1050-6. PubMed ID: 2528337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma.
    Asano N; Suzuki R; Matsuo K; Kagami Y; Ishida F; Tamaru JI; Jin GS; Sato Y; Shimoyama Y; Yoshino T; Morishima Y; Nakamura S
    Histopathology; 2007 May; 50(6):705-15. PubMed ID: 17493234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.
    Oyama T; Yamamoto K; Asano N; Oshiro A; Suzuki R; Kagami Y; Morishima Y; Takeuchi K; Izumo T; Mori S; Ohshima K; Suzumiya J; Nakamura N; Abe M; Ichimura K; Sato Y; Yoshino T; Naoe T; Shimoyama Y; Kamiya Y; Kinoshita T; Nakamura S
    Clin Cancer Res; 2007 Sep; 13(17):5124-32. PubMed ID: 17785567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
    Senff NJ; Willemze R
    Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary CNS lymphoma treated with combined intra-arterial ACNU and radiotherapy.
    Sonoda Y; Matsumoto K; Kakuto Y; Nishino Y; Kumabe T; Tominaga T; Katakura R
    Acta Neurochir (Wien); 2007 Nov; 149(11):1183-9; discussion 1189. PubMed ID: 17712511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
    Imai H; Shimada K; Shimada S; Abe M; Okamoto M; Kitamura K; Kinoshita T; Shiraishi T; Nakamura S
    Pathol Int; 2009 Jul; 59(7):431-7. PubMed ID: 19563405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
    Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
    Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.